Stay updated on PV-10 with Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the PV-10 with Pembrolizumab in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision has been updated to v3.6.5, indicating a maintenance update to the ClinicalTrials.gov study page. This change does not modify trial data or eligibility.SummaryDifference0.1%

- Check26 days agoChange DetectedMelanoma is now listed as a focus topic for the study, aligning the page with the disease being investigated. The related topics section has been updated to include MedlinePlus Genetics, providing quick access to genetic resources relevant to the condition.SummaryDifference0.2%

- Check34 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a new version of the page managed by the site. This change appears to be a backend/update/version bump rather than a visible content modification.SummaryDifference0.1%

- Check41 days agoChange DetectedRemoved the Melanoma topic, the Related topics block, and the MedlinePlus Genetics entry from the page’s related topics/MeSH metadata. This changes how the study is indexed and surfaced for users browsing disease- or genetics-related resources.SummaryDifference0.2%

- Check48 days agoChange DetectedMelanoma and MedlinePlus Genetics were added as related topics in the page's taxonomic/related-content sections. These additions provide new cross-links to melanoma information and genetics resources, aiding navigation to additional background materials.SummaryDifference0.2%

- Check55 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page. This reflects a minor version update without changing study details.SummaryDifference0.1%

Stay in the know with updates to PV-10 with Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.